Savaysa (edoxaban) is an anticoagulant that reduces the risk of stroke in people with atrial fibrillation not caused by a heart valve problem. It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE) after initial treatment with an injectable blood thinner. Savaysa works by blocking certain clotting substances in the blood to prevent dangerous clots.